FDA authorizes novel point-of-care antigen test

Aug 20, 2020 - 03:25 PM
FDA product update

The Food and Drug Administration yesterday authorized emergency use of a rapid point-of-care antigen test to detect SARS-CoV-2 directly from nasal swab specimens.

Laboratories certified under the Clinical Laboratory Improvement Amendment to perform moderate, high or waived complexity tests and health care providers with a CLIA certificate of waiver, compliance or accreditation may use the test, made by LumiraDx UK Ltd.

Assistant Secretary for Health Admiral Brett Giroir, M.D., said the novel “low cost” test “will significantly contribute to our scaling up and expanding testing platforms for SARS-CoV-2. This technology has built-in digital connectivity, almost everything we hope for in new testing platforms coming to market. Furthermore, its flexibility to perform diagnostic assays to detect indicators of various diseases, including inflammatory markers, could be transformative in providing improved access to quality health care.”

Related News Articles

Headline
FDA announces recall of cefazolin by Sandoz for mislabeling
The Food and Drug Administration July 15 announced a recall by Sandoz on certain lots of cefazolin, due to the lots being mislabeled as penicillin G potassium…
Headline
COVID-19 vaccination approved for older adults and high-risk, younger children
 The Food and Drug Administration July 10 approved Moderna’s Spikevax COVID-19 vaccine for children under 12 with at least one underlying condition that…
Headline
OSHA proposes removing remaining requirements of its COVID-19 emergency temporary standard
The Occupational Safety and Health Administration June 30 released a proposed rule to remove what remains of its emergency temporary standard for occupational…
Headline
RFK Jr. says CDC will no longer recommend COVID-19 vaccine for healthy children, pregnant women
Department of Health and Human Services Secretary Robert F. Kennedy Jr. May 27 announced in a post on X that the Centers for Disease Control and Prevention…
Headline
FDA to limit COVID-19 vaccine to people over 65, others at high risk for serious illness
Leaders of the Food and Drug Administration May 20 announced new guidelines for administering the COVID-19 vaccine in a paper published by the New England…
Headline
Study finds driving with COVID-19 raises crash risk by 25%
A study published April 8 by the Public Library of Science’s Journal of Global Public Health found that driving while infected with COVID-19 raises the risk of…